000			02204 a2200613 4500
005			20250516175927.0
264		0	_c20150413
008			201504s 0 0 eng d
022			_a1592-8721
024	7		_a10.3324/haematol.2013.093187 _2doi
040			_aNLM _beng _cNLM
100	1		_aChaudhuri, Leena
245	0	0	_aCHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. _h[electronic resource]
260			_bHaematologica _cApr 2014
300			_a688-96 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAtaxia Telangiectasia Mutated Proteins _xantagonists & inhibitors
650	0	4	_aCell Cycle Proteins _xantagonists & inhibitors
650	0	4	_aCell Line, Tumor
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Synergism
650	0	4	_aGene Expression Profiling
650	0	4	_aGene Silencing
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aNuclear Proteins _xantagonists & inhibitors
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProtein Kinases _xgenetics
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aPyrimidinones
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aSignal Transduction
650	0	4	_aTumor Stem Cell Assay
700	1		_aVincelette, Nicole D
700	1		_aKoh, Brian D
700	1		_aNaylor, Ryan M
700	1		_aFlatten, Karen S
700	1		_aPeterson, Kevin L
700	1		_aMcNally, Amanda
700	1		_aGojo, Ivana
700	1		_aKarp, Judith E
700	1		_aMesa, Ruben A
700	1		_aSproat, Lisa O
700	1		_aBogenberger, James M
700	1		_aKaufmann, Scott H
700	1		_aTibes, Raoul
773	0		_tHaematologica _gvol. 99 _gno. 4 _gp. 688-96
856	4	0	_uhttps://doi.org/10.3324/haematol.2013.093187 _zAvailable from publisher's website
999			_c23220065 _d23220065